CDC Online Newsroom

Tick season is here and that means it's time once again for people to protect themselves and their loved ones (including pets) from tick bites. CDC has an updated digital press kit available for journalists with the latest information about the

Almost half of all U.S. worksites offered some type of health promotion or wellness program in 2017, according to a new study published today in the American Journal of Health Promotion. The findings of the report show that worksite health promotion

CDC has posted an investigation notice about a multistate outbreak of Listeria infections linked to deli-sliced meats and cheeses. https://www.cdc.gov/listeria/outbreaks/deliproducts-04-19/index.html

A CDC food safety alert about a multistate outbreak of Salmonella infections linked to frozen, raw ground tuna has been posted at https://www.cdc.gov/salmonella/newport-04-19/index.html.

A CDC investigation update of a multistate outbreak of E. coli O103 infections has been posted https://www.cdc.gov/ecoli/2019/o103-04-19/index.html. At this time, a source of these infections has not been identified.

A CDC investigation notice of a multistate outbreak of E. coli O103 infections has been posted https://www.cdc.gov/ecoli/2019/o103-04-19/index.html. At this time, a source of these infections has not been identified.

The Centers for Disease Control and Prevention (CDC) and Agency for Toxic Substances and Disease Registry (ATSDR) are soliciting research applications to conduct a multi-site study on the human health effects of exposures to per- and polyfluoroalkyl

New emotionally powerful ads today kick off the eighth year of the Centers for Disease Control and Prevention's (CDC) "Tips From Former Smokers" campaign. The new ads share personal stories of Americans suffering from smoking-related illnesses-and

A CDC investigation update of a multistate outbreak of Salmonella infections linked to contact with pet hedgehogs has been posted: https://www.cdc.gov/salmonella/typhimurium-01-19/index.html.

CDC is issuing new guidance to clinicians for the treatment of severe malaria cases in the United States (U.S.). This change in treatment protocol is necessary because the only FDA-approved intravenous (IV) antimalarial drug in the U.S., quinidine